OnPoint OsteoCentric Funding II, LP — Form D
OnPoint OsteoCentric Funding II, LP of DALLAS, TX, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-01-02. $8.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-01-02
- Form: D
- Accession: 0001797789-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $8.3M
- Investors: 25
- Date of first sale: 2019-11-15
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-356934
Issuer
- Name: OnPoint OsteoCentric Funding II, LP
- CIK: 0001797789
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 7001 PRESTON ROAD, DALLAS, TX, 75205
- Phone: 214-449-2622
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Todd NA Travers | Executive Officer | Dallas, TX |
| Reed NA Williams | Executive Officer | Dallas, TX |
| N/A NA OnPoint Advisors, LLC | Promoter | Dallas, TX |
| N/A NA OnPoint Companies, LLC | Promoter | Dallas, TX |
More